Follow the 보로노이 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 보로노이 has recorded 59 public disclosures. Market capitalisation: €3,120.1bn. The latest transaction was reported on 22 June 2026 (Other). Among the most active insiders: 김현태. Every trade is openly available.
59
Insider Decl.
0
Thresholds
·
19 ops.
Buy Volume
·
5 ops.
Sell Volume
26Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,850 of 26,212 companies
39.8
score / 100
Value
28
Quality
52
FCF yld-2.4%
Earn yld-1.4%
EV/EBITDA·
ROE-70%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Boronois operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions in the medical field.